Literature DB >> 23502987

Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry).

Naoki Sato1, Katsuya Kajimoto, Takehiko Keida, Masayuki Mizuno, Yuichiro Minami, Dai Yumino, Kuniya Asai, Koji Murai, Ryo Muanakata, Toshiyuki Aokage, Yasushi Sakata, Kyoichi Mizuno, Teruo Takano.   

Abstract

BACKGROUND: Hospitalized heart failure (HHF) is a critical issue in Japan. To improve its management and outcomes, the clinical features, in-hospital management, and outcomes should be analyzed to improve the guidelines for HHF. METHODS AND
RESULTS: The acute decompensated heart failure syndromes (ATTEND) registry is the largest study of HHF in Japan. The present report covers the clinical features and in-hospital management of HHF patients. The data from 4,842 enrolled patients have demonstrated that most Japanese HHF patients are elderly, with new onset, and a history of hypertension and orthopnea on admission. During hospitalization, furosemide and carperitide were commonly used and the length of stay was extremely long (mean 30 days), with 6.4% in-hospital mortality.
CONCLUSIONS: The findings of the present study suggest the following: (1) the focus for hypertensive elderly and diabetic patients should be on primary prevention of HHF,(2) more intensive management with noninvasive positive pressure ventilation should be performed at the urgent stage, (3) it is necessary to clarify the clinical benefit of carperitide and angiotensin-receptor blockers, because they are commonly used in Japan, and (4) it is necessary to clarify the relationship between in-hospital mortality and length of stay from the viewpoint of both outcome and cost of patient care.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23502987     DOI: 10.1253/circj.cj-13-0187

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  56 in total

1.  Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.

Authors:  Stephen J Greene; Ami N Shah; Javed Butler; Andrew P Ambrosy; Stefan D Anker; Ovidiu Chioncel; Sean P Collins; Wilfried Dinh; Preston M Dunnmon; Gregg C Fonarow; Carolyn S P Lam; Robert J Mentz; Burkert Pieske; Lothar Roessig; Giuseppe M C Rosano; Naoki Sato; Muthiah Vaduganathan; Mihai Gheorghiade
Journal:  Am Heart J       Date:  2014-05-24       Impact factor: 4.749

Review 2.  Pharmacological Treatment of Heart Failure with Preserved Ejection Fraction.

Authors:  Kazuhiro Yamamoto
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

Review 3.  Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.

Authors:  Andrew P Ambrosy; Mihai Gheorghiade; Ovidiu Chioncel; Robert J Mentz; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2014-12

4.  Prognostic benefit of acute heart failure associated with atherosclerosis: the importance of prehospital medication in patients with severely decompensated acute heart failure.

Authors:  Hirotake Okazaki; Akihiro Shirakabe; Noritake Hata; Nobuaki Kobayashi; Masato Matsushita; Yusaku Shibata; Suguru Nishigoori; Saori Uchiyama; Kazutaka Kiuchi; Kuniya Asai; Wataru Shimizu
Journal:  Heart Vessels       Date:  2018-06-26       Impact factor: 2.037

Review 5.  Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps.

Authors:  Robert J Mentz; Lothar Roessig; Barry H Greenberg; Naoki Sato; Kaori Shinagawa; Daniel Yeo; Bernard W K Kwok; Eugenio B Reyes; Henry Krum; Burkert Pieske; Stephen J Greene; Andrew P Ambrosy; Jacob P Kelly; Faiez Zannad; Bertram Pitt; Carolyn S P Lam
Journal:  JACC Heart Fail       Date:  2016-06       Impact factor: 12.035

6.  TSOC-HFrEF Registry: A Registry of Hospitalized Patients with Decompensated Systolic Heart Failure: Description of Population and Management.

Authors:  Chun-Chieh Wang; Hung-Yu Chang; Wei-Hsian Yin; Yen-Wen Wu; Pao-Hsien Chu; Chih-Cheng Wu; Chih-Hsin Hsu; Ming-Shien Wen; Wen-Chol Voon; Wei-Shiang Lin; Jin-Long Huang; Shyh-Ming Chen; Ning-I Yang; Heng-Chia Chang; Kuan-Cheng Chang; Shih-Hsien Sung; Kou-Gi Shyu; Jiunn-Lee Lin; Guang-Yuan Mar; Kuei-Chuan Chan; Jen-Yuan Kuo; Ji-Hung Wang; Zhih-Cherng Chen; Wei-Kung Tseng; Wen-Jin Cherng
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

7.  The relationship between the time until commencement of tolvaptan and the length of hospital stay in heart failure patients.

Authors:  Shunsuke Kiuchi; Shinji Hisatake; Takayuki Kabuki; Takashi Oka; Shintaro Dobashi; Takahiro Fujii; Takanori Ikeda
Journal:  Heart Vessels       Date:  2017-11-11       Impact factor: 2.037

8.  Good response to tolvaptan shortens hospitalization in patients with congestive heart failure.

Authors:  Tomohito Kogure; Kentaro Jujo; Kazuyuki Hamada; Katsumi Saito; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2017-11-11       Impact factor: 2.037

9.  How to Improve Time to Diagnosis in Acute Heart Failure - Clinical Signs and Chest X-ray.

Authors:  Christopher J Allen; Kaushik Guha; Rakesh Sharma
Journal:  Card Fail Rev       Date:  2015-10

10.  Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure.

Authors:  Yasuhiro Hamatani; Moritake Iguchi; Michikazu Nakamura; Ryo Ohtani; Yugo Yamashita; Daisuke Takagi; Takashi Unoki; Mitsuru Ishii; Nobutoyo Masunaga; Hisashi Ogawa; Mio Hamatani; Mitsuru Abe; Masaharu Akao
Journal:  Heart Vessels       Date:  2015-07-29       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.